NCT01845064View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

November 30, 2014

Conditions
Diabetes Type 2
Interventions
DRUG

DM199

DRUG

Placebo

Trial Locations (1)

9471 GP

PRA, Zuidlaren

Sponsors
All Listed Sponsors
lead

DiaMedica Therapeutics Inc

INDUSTRY

NCT01845064 - A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter